secwatch.observer — SEC 8-K summary
======================================

Issuer:     LB PHARMACEUTICALS INC (LBRX)
CIK:        0001691082
Form:       8-K
Filed at:   2026-03-16T23:59:59+00:00
Accession:  0001193125-26-108474
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Zachary Prensky to retire from LB Pharmaceuticals board at 2026 annual meeting
--------------------------------------------------------------------------------

- Zachary Prensky notified board on March 13, 2026; will not stand for reelection at the 2026 annual meeting.
- Prensky remains on board and Nominating & Governance Committee until the meeting concludes.
- Decision was not due to any disagreement with the company; he will provide consulting services post-retirement.
- Amendment to Transition Agreement allows unvested stock options to continue vesting during the consulting term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1691082/000119312526108474/0001193125-26-108474-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1691082/000119312526108474/d105454d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-108474

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer